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follow-up, a reduction in major adverse cardiac events (MACE) was observed with
second-generation compared to first-generation DES (5.6 vs. 16.1%, p0.20), driven by
a four-fold decrease in target vessel revascularization (2.9 vs. 14.8%, p0.09), although
not reaching statistical significance. Only 1 patient (1.6%) in the first-generation DES and
none in the second-generation DES had definite stent thrombosis (Table).
Conclusion: In this study of full metal jacket stenting for diffuse lesions, second-
generation DES compared to first-generation DES demonstrated a favorable trend
toward reduction in repeat revascularization and MACE at 1-year with acceptable safety
profile.
Clinical outcomes at 1-year between first and second generation DES
Second-
generation
DES (n36)
First-
generation
DES (n62) P value
Major adverse cardiac events 2 (5.6%) 10 (16.1%) 0.20
Death 1 (2.8%) 1 (1.6%) 1.00
Q-wave myocardial infarction 0 0 -
Target vessel revascularization 1 (2.9%) 9 (14.8%) 0.09
Target lesion revascularization 1 (2.9%) 7 (11.5%) 0.25
Deﬁnite stent thrombosis 0 1 (1.6%) 1.00
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Three Years Follow Up Data Demonstrate Safe And Effective Treatment Of De Novo
Calcified Coronary Lesions By Orbital Atherectomy System
Keyur Parikh, Roosha Parikh, Apurva Patel, Milan Chag
Care Institute of Medical Sciences, Ahmedabad, India
Background: Coronary Artery Disease continues to be a widespread and growing
problem worldwide. Performing PCI on calcified lesions can lead to higher MACE rates
and stent under expansion/malapposition. The Orbit I trial was conducted to evaluate the
safety and performance of the Diamondback 360 Orbital Atherectomy System (OAS)
(Cardiovascular Systems, Inc., St. Paul, MN, USA) for the treatment of calcified coronary
lesions.
Methods: From May 2008 to July 2008, 33 patients were enrolled in ORBIT I study
based on several criteria, including a de novo, coronary lesion with stenosis 50% and
100% and at least one quadrant of calcification via IVUS. The patients were treated with
OAS prior to stent placement. The patients were followed for 36 months at Care Institute
of Medical Sciences, Ahmedabad, India to evaluate the MACE rate.
Results: Of the 33 patients, 90.90% (n30/33) were males with an average age of 54.9
years. The ACC/AHA lesion class was: Type A 6.06% (n2/33); Type B1 33.33%
(n11/33); Type B2 60.60% (n20/33). The % diameter stenosis was 85.75%; lesion
length was 15.90 mm. The procedural success was 97% (32/33) with one case where
IVUS/device was not able to cross the lesion due to severe calcification. All stents were
successfully deployed with 0.3% 1.8% residual stenosis. The observed MACE rate was
as follows: in-hospital 6.06% (n2/33); 30 days 9.09% (n3/33); 6 months 12.12%
(n4/33); 24 months 15.15% (n5/33); and 36 months 18.18% (n6/33). MACE rate
comprised of 2 patients with a non Q-wave MI in-hospital; one patient with non Q-wave
MI at 30 days that led to TLR; and one patient with cardiac death at 6 months, 24
months and 36 months, respectively.
Conclusion: This case series demonstrates that OAS safely and effectively modified
calcified lesions and facilitated stent delivery in this difficult-to-treat plaque morphology,
which continues up to three years post index procedure.
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Hyperinvasive Approach To Out-of Hospital Cardiac Arrest Using Mechanical Chest
Compression Device, Prehospital Intraarrest Cooling, Extracorporeal Life Support
And Early Invasive Assessment Compared To Standard Of Care. A Randomized
Parallel Groups Comparative Study. “Prague Ohca Study. Results Of Presimulation
And Simulation Phase
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Background: Out of hospital cardiac arrest (OHCA) has a poor outcome. Recent
non-randomized studies of ECLS (extracorporeal life support) in OHCA suggested
further studies to define population that would benefit from ECLS. Ongoing prospective
randomized study compares prehospital intraarrest hypothermia combined with mechan-
ical chest compressions, intrahospital ECLS and early invasive assessment in refractory
OHCA of presumed cardiac origin compared to a standard of care. This abstract describes
methodology of the trial and results of presimulation and simulation phase.
Methods: Patients with witnessed OHCA without ROSC (return of spontaneous
circulation) after a minimum of 5 minutes of ACLS (advanced cardiac life support) by
emergency medical service (EMS) team are randomized to standard vs. hyperinvasive arm.
In hyperinvasive arm, mechanical compression device together with intranasal evaporative
cooling is instituted and patients are transferred directly to cardiac center under ongoing
cardiopulmonary resuscitation. After admission, ECLS inclusion/exclusion criteria are
evaluated and if achieved, veno-arterial ECLS is started. Invasive investigation and
standard postresuscitation care follows immediately. Patients in standard arm are managed
on scene. When ROSC is achieved, patients are transferred to cardiac center and further
treated as per recent guidelines. During the presimulation phase mechanical chest
compression device has been used routinely in all patients with OHCA, during the
simulation phase patients were to practice the logistics of the study.
Results: Since January until October 2012 we enrolled 40 patients, 32 to presimulation
and 8 to simulation protocol. Average age was 61 years (21-87), 85% were men. Acute
coronary syndrome was the cause in 21 (53%) patients, STEMI 17 (43%), cardiac origin
of OHCA was identified in 63% of patients. Average time until ROSC was 40 minutes,
median 32 minutes (15-120). Twenty (50%) patients survived, CPC (Cerebral
Performance Category) 12 during hospitalization reached 15 of 20 survivors
(75%) and 1 of 20 nonsurvivors (5%). Survival in patients admitted under ongoing
CPR was 5 of 17 (30%).
Discussion: A combined, hyperinvasive approach to refractory OHCA is a viable option
with challenging preliminary results. The protocol is opened for sharing by other cardiac
centers with available ECLS and cathlab teams trained to admit patients with refractory
cardiac arrest under ongoing CPR. Supported by IGA NT 13225-4/2012, registered
under ClinicalTrials.gov NCT01511666.
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Renal Artery Denervation in Chronic Kidney Disease Patients
Amitabh Yaduvanshi, Mohan Nair
Maxhealthcare, New Delhi, India
Renal Denervation Therapy (RDN) have been proven to be useful in resistant hyperten-
sion patients. The Symplicity Trials did not include patients with renal disease whereas,
a significant number of end stage renal disease (ESRD) patients who have resistant
hypertension despite being on multiple drugs and the benefits of RDN in such patients
have not been reported.
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Here we describe a series of 5 cases in which RDN was performed in patients with
ESRD and resistant hypertension. The RF energy was delivered using the standard RF
delivery system that is used in cardiac electrophysiology lab and a standard 5F, 4mm tip
RF ablation catheter was used. Additionally multiple 3 dimensional imaging and catheter
monitoring modalities were used to precisely pinpoint the site of RF energy delivery. Dyna
CT, a novel 3D imaging tool was used to precisely define the anatomy and annotate the
radiofrequency lesions given in a spiral fashion along the length of the arteries. In addition,
non fluoroscopic anatomy was created using the NavX Version 3 system.
The procedure was completed without any complications in all 5 patients. The average
procedure time was 28 min and average of 5.6 lesions was given in each renal artery. Post
procedure renal parameters did not show any significant difference at 48 hrs and at 1
month followup.
There was a significant drop in blood pressure in all the patients 38  18 mmHg in
systolic and 16 14 mmHg fall in diastolic BP at 1week follow up and 39 22 mmHg
systolic , 18  13 mmHg fall in diastolic BP at 1 month follow up.
To the best of our knowledge, this is the first time in the world that such precision
technology has been used to guide this promising new therapy. This also is amongst the
first case series of renal failure patients treated with renal denervation. This is also the first
report of usage of standard RF ablation catheters for renal denervation and has the
potential of widespread usage in labs already equipped with EP systems without any
additional expenditure.
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Catheter Ablation of Hemodynamically Unstable Ventricular Tachycardia under
Support of Left Ventricular Assist Device
Fei Lu, Ioanna Apostolidou, Kenneth Liao, Ranjit John, Peter Eckman, Gladwin Das,
David Benditt, Daniel Garry
University of Minnesota, Minneapolis, MN
Background: Although hemodynamically unstable ventricular tachycardia (VT) may be
ablated with the aid of mechanical hemodynamic support, little is known regarding the
impact of possible hypo-perfusion of vital organs during such procedures.
Objective: This study investigated whether catheter ablation of unstable VT in the
presence of mechanical hemodynamic support may cause acute renal injury.
Methods: Between April 22 2009 and September 14 2012, 15 consecutive patients (aged
63 12 years with left ventricular ejection fraction of 19 9%) who underwent ablation
of hemodynamically unstable VT were included in this study. Hemodynamic support
included percutaneous (Impella, n5) and implantable (n7) left ventricular assist device
(LVAD) and percutaneous cardiopulmonary bypass (CPB, n5).
Results: Except for 2 case in which Impella® was used, hemodynamic support was
considered adequate (with consistent mean blood pressure of 60 mmHg). VT was
terminated at least once during ablation in all patients. Hemolysis was observed in 1
patient with Impella, and failure to insert Impella due to access problem was encountered
in another. Surgical intervention was needed in 2 patients with Impella due to bleeding
and entangled Preclose® device, respectively. The mean time under hemodynamic support
was 243  96 minutes, and time in VT was 98  67 minutes. There was no significant
change in creatinine, blood urea nitrogen, or glomerular filtration rate (GFR) at days 1
and 3 after the procedure compared to baseline values in all patients except one using
Impella with bleeding and inadequate hemodynamic support.
Conclusion: Our data suggest that percutaneous CPB and implantable LVAD provide
adequate hemodynamic support for ablation of unstable VT as evidenced by unchanged
renal function after procedure. Impella, on the other hand, was associated with more
complication risk, and may not provide sufficient hemodynamic support in unstable VT
patients.
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Efficacy and Safety of Adjuvant Proximal Balloon Inflation Comprising Stent
Proximal Edge for Full Expansion of the Stent by Stent Balloon
Seung-Woon Rha, Byoung Geol Choi, Se Yeon Choi, Sung Il Im, Sun Won Kim,
Jin Oh Na, Cheol Ung Choi, Hong Euy Lim, Jin Won Kim, Eung Ju Kim,
Chang Gyu Park, Hong Seog Seo, Dong Joo Oh
Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea, Republic of
Background: Another shorter & bigger non-compliant balloon is being used for optimal
expansion of the stent, particularly the proximal portion of the stent when the proximal
and distal reference vessel diameters(RVD) are significantly different. The safety and
efficacy of adjuvant proximal balloon inflation (PBI) comprising proximal edge of the stent
using stent balloon with higher inflation pressure are largely unknown. This strategy was
intended to reduce procedural time, contrast amount and cost when we do the adjuvant
ballooning for optimal stent expansion.
Methods: This study consisted of 2164 consecutive patients (pts) underwent percuta-
neous coronary intervention (PCI) with drug-eluting stents (DESs). A total 211 pts (259
lesions) have performed PBI using same stent balloon. 6-month angiographic and
12-months clinical outcomes were compared between the PBI group and non-PBI group.
Results: The baseline clinical and procedural characteristics were balanced between the
two groups, except that the left circumflex lesions were more common in the PBI group.
There was no difference in procedural success rate and in hospital complications between
the two groups, except that the incidence of peri-procedural myocardial infarction (MI,
5.8% vs. 10.4%, P0.001) was higher in the PBI group. At 6-month, the follow up
minimal luminal diameter (MLD) was smaller in the PBI group. However, this
angiographic benefit was not translated into the clinical benefit up to 12 months. (Table).
Conclusion: PBI was associated with higher incidence of peri-procedural MI but other
safety profiles, procedural success, in-hospital complications, mid-term angiographic and
clinical outcomes were similar with those of non-PBI group. PBI can be a cost-effective
strategy when the proximal and distal RVD are significantly different at the time of stent
implantation.
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Percutaneous Thrombectomy With Primary Coronary Right Judkins 8 French Guide
For The Treatment Of Acute Pulmonary Embolism High Risk
Hugo Gutierrez-Leonard, Sr., Jose Luis Ojeda-Delgado, Luis Berumen-Dominguez,
Moises Rodriguez-Regino, Violeta Valencia, Miguel Ramirez-Aldaraca,
Victor Manuel Diaz de Anda
Hospital Militar, Mexico, Mexico
Objective: A) patency of the pulmonary arteries by thrombus aspiration with right
coronary guide catheter. B) Improve the function of the right ventricle. Reduce mortality.
Material: A total of 38 patients, 20 female and 18 male between 28 and 64 years from
March 2009 to April 2012. In 37 patients the obstruction was bilateral in all patients, the
degree of obstruction was greater than 80% of the main branches. In all cases, introducing
a long metal 8 french by 80cm in length and 8 french catheter coronary Judkins guide and
a 20ml syringe. the diagnosis was formulated with pulmonary angiotomography echocar-
diogram.
Method: By puncturing the femoral vein was placed a metal sheath of 8 french by 80cm
in length to the trunk of the pulmonary artery and this was passed through a guide
catheter handle 4 Judkin right coronary to the site of thrombosis and 20ml syringe practice
is sustained suction catheter to remove it slowly withdrawing the introducer. subsequently
purging the catheter to remove thrombi were aspirated. This maneuver was repeated
several times and finally a practical handbook with this catheter angiography to confirm
the patency of the pulmonary branches.
Results: In all cases it was possible achievement for all thrombi. was obtained
permeability of the pulmonary branches of 80% saturation was restored and blood pressure
in the next few hours. Of the 38 patients, one died during the procedure and another
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